Citadel Advisors
DCOY

Citadel Advisors’s Decoy Therapeutics DCOY Stock Holding History

Citadel Advisors’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-17
Closed -$15.7K – 15449
2023
Q4 		$15.7K Buy
+17
New +$17K ﹤0.01% 12828
2022
Q3 		– Sell
-5
Closed -$35K – 13727
2022
Q2 		$35K Buy
+5
New +$43.1K ﹤0.01% 12144
2021
Q3 		– Sell
-2
Closed -$91K – 14717
2021
Q2 		$91K Buy
+2
New +$89K ﹤0.01% 12989
2021
Q1 		– Hold
0
– – – 13070
2019
Q1 		– Hold
0
– -$20K – 9898
2018
Q4 		– Hold
0
– – – 8758
2016
Q3 		– Hold
0
– -$104K – 7855
2016
Q2 		– Hold
0
– – – 6176
2016
Q1 		– Hold
0
– -$59K – 7909
2015
Q4 		– Hold
0
– – – 7172

Other funds holding DCOY

AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return